Cara Therapeutics Announces Positive Results From Human Abuse Liability Trial Of Peripheral Opioid For Acute Pain, I.V. CR845

By: via Benzinga
Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.